Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease

NCT00004315 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

NIH

Sponsor class

Conditions

Cystic Fibrosis
Gastrointestinal Diseases
Cholestasis

Interventions

DRUG: ursodiol

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]